A Quantitative Estimate of the Expected Shortening of the Median Isolation Period of Patients With COVID-19 After the Adoption of a Symptom-Based Strategy.

ABSTRACT

A long period of isolation was observed in patients hospitalized for COVID-19 in Milan over March-September 2020 (45; IQR 37-54 days). A significantly shorter period would have been observed by the application of May-WHO (22, IQR 17-30 days, P < 0.001) and October-Italian (26, IQR 21-34 days, P < 0.001) Guidelines. The adoption of the new symptom-based criteria is likely to lead to a significant reduction in the length of the isolation period with potential social, economic and psychological benefits, particularly in the younger population with mild/moderate disease and no comorbidities. In our opinion, the release from isolation after 21 days from symptoms onset, even without a PCR diagnostic test, in most cases seems the most adequate strategy that could balance precautions to prevent SARS CoV-2 transmission and unnecessary prolonged isolation or overuse of diagnostic testing.